OB/GYNs and other reproductive healthcare providers need to find out during contraceptive and pregnancy counseling whether their patients are using or have plans to use ketamine, a drug that is becoming more common for use among psychiatric patients, new research says.
Providers Need to Know if Patients Are Receiving Ketamine Treatments
Concern is that ketamine can affect embryo’s neurodevelopment
November 1, 2024